Analyst Price Targets — CAR
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 23, 2026 11:44 am | — | Goldman Sachs | $85.00 | $96.47 | TheFly | Avis Budget price target lowered to $85 from $111 at Goldman Sachs |
| December 8, 2025 10:23 am | — | Morgan Stanley | $142.00 | $134.85 | TheFly | Avis Budget downgraded to Equal Weight from Overweight at Morgan Stanley |
| November 3, 2025 11:32 am | — | Barclays | $120.00 | $136.07 | TheFly | Avis Budget price target lowered to $120 from $150 at Barclays |
| October 29, 2025 11:49 am | Christopher Stathoulopoulos | Susquehanna | $130.00 | $141.27 | TheFly | Avis Budget price target lowered to $130 from $145 at Susquehanna |
| October 9, 2025 10:58 am | — | Susquehanna | $145.00 | $146.32 | TheFly | Avis Budget price target lowered to $145 from $150 at Susquehanna |
| September 19, 2024 4:32 am | Dan Levy | Barclays | $105.00 | $85.08 | TheFly | Avis Budget initiated with an Equal Weight at Barclays |
| April 30, 2024 7:10 am | Christopher Stathoulopoulos | Susquehanna | $117.00 | $103.56 | TheFly | Avis Budget price target lowered to $117 from $145 at Susquehanna |
| April 10, 2024 6:12 am | Adam Jonas | Morgan Stanley | $187.00 | $123.56 | StreetInsider | Avis Budget Group (CAR) PT Lowered to $187 at Morgan Stanley |
| April 4, 2024 2:36 am | Lizzie Dove | Goldman Sachs | $130.00 | $121.11 | StreetInsider | Goldman Sachs Upgrades Avis Budget Group (CAR) to Neutral |
| March 25, 2024 6:56 am | John Healy | Northcoast Research | $155.00 | $117.57 | StreetInsider | Northcoast Research Upgrades Avis Budget Group (CAR) to Buy |
Latest News for CAR
A lasting end to the war in Iran would almost certainly be welcome news for tech companies' bottom lines.
The Nasdaq is up 0.51% while the S&P 500 has gained 0.25%.
Hertz Global Holdings (NASDAQ:HTZ) stock is down 7% in midday trading, slipping from $6.99 to less than $6.50.
Grupo Aeroportuario del Sureste (NYSE: ASR - Get Free Report) and Avis Budget Group (NASDAQ: CAR - Get Free Report) are both large-cap transportation companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations. Profitability This table compares
NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has acquired an exclusive worldwide license to a patented chimeric antigen receptor (CAR) technology platform for precision-enhanced augmentation of therapeutic mesenchymal lineage stromal cell (MSC) products. Mesoblast plans to…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CAR.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.